These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 5587156)

  • 1. [Contribution to bronchospasmolytic therapy in infants, children and adults].
    Fladung H
    Med Welt; 1967 Mar; 11():654-6. PubMed ID: 5587156
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of spastic bronchitis in infants and children using a new bronchospasmolytic agent].
    Ertogan F; Stolting G; Russ D
    Dtsch Med J; 1969 Jun; 20(12):413-5. PubMed ID: 5801770
    [No Abstract]   [Full Text] [Related]  

  • 3. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
    Pelz HH
    Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Asthmalitan Depot-tablets].
    Ther Ggw; 1973 Nov; 112(11):1816 passim. PubMed ID: 4778533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
    Nachtigall C
    Med Monatsschr; 1968 Dec; 22(12):555-7. PubMed ID: 5709425
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the bronchospasmolytic activity of alupent and ipradol].
    Makel'skiĭ VV; Iartsev SS
    Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the treatment of spastic bronchitis in infancy].
    Habermann P
    Med Welt; 1968 May; 21():1342-4. PubMed ID: 5721333
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchodilators.
    Cochrane GM
    Practitioner; 1979 Oct; 223(1336):489-98. PubMed ID: 523401
    [No Abstract]   [Full Text] [Related]  

  • 10. Hexoprenaline--a new bronchodilator.
    Vermaak JC; De Kock MA; Joubert JR
    S Afr Med J; 1972 Dec; 46(51):1999-2001. PubMed ID: 4651880
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the value and effectiveness of the use of an association of an isoproterenol derivative and calcium iodide in respiratory tract diseases in the aged].
    Barbieri R; Michetti A
    Minerva Med; 1971 May; 62(36):1858-69. PubMed ID: 5580497
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current position of disodium cromoglycate in the therapy of broncho-asthmatic syndromes].
    Bariffi F; Caputi M; Olivieri D
    Arch Monaldi; 1972; 27(1):35-43. PubMed ID: 4631441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K
    Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rectal therapy of asthmoid and spastic bronchitis and whooping cough in infancy and in the newborn with Priatan].
    Opitz CA
    Hippokrates; 1967 May; 38(10):408-10. PubMed ID: 5612004
    [No Abstract]   [Full Text] [Related]  

  • 16. [The bronchoexpanding effects of phenylephrine and its combination with isoprenaline in comparison with other bronchodilator agents].
    Langer I
    Acta Allergol; 1967 Dec; 22(6):419-46. PubMed ID: 5630525
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of bronchodilators on spastic bronchitis in childhood (author's transl)].
    Hlavatý J; Resetár M
    Bratisl Lek Listy; 1981 Aug; 76(2):225-30. PubMed ID: 7260687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with hexoprenaline, a new broncholytic agent].
    Hartl O
    Wien Med Wochenschr; 1972 Feb; 122(8):121-6. PubMed ID: 5012665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double blind study of bronchospasmolytic effect of ucb 1402 in comparison with a placebo].
    Alexander F; Flahaut J; Raveschot H
    Acta Tuberc Pneumol Belg; 1968; 59(4):661-6. PubMed ID: 4904308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with Perspiran prot. in specialized lung practice].
    Gordt W
    Landarzt; 1966 Oct; 42(28):1260-4. PubMed ID: 5928684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.